Tombot makes robotic animals that transform the daily life of individuals, families and communities facing health adversities. Designed to provide specific medical benefits for seniors with dementia, Tombot Puppies have been pre-ordered for residential, assisted living, skilled nursing and acute care applications. Tombot Puppies have also been preordered for seniors subjected to social isolation due to COVID-19, children with Autism, adults with high impact chronic pain, major depressive disorder, anxiety, bipolar disorder, and PTSD. Peer-reviewed studies show that robotic animals positively affect some peoples’ ability to cope with stress, anxiety, loneliness, depression and pain, improving quality of life and reducing the need for psychotropic and opioid medications. Tombot Puppies will be the first robotic animals to be both FDA medical devices and remote patient monitoring platforms.